Reportlinker Adds The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Produ... (es and/or sub-segments were selected tha...)

HOME >> MEDICINE >> NEWS

Reportlinker Adds The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets

Date:10/8/2009

es and/or sub-segments were selected that will particularly be affected by wellness programs. Products, services and/or sub-segments that are not expected to be significantly impacted were not included.

Sales estimates for each market segment represent U.S. revenues and are expressed in current dollars. Estimates are provided for the historic 2004 - 2008 period and forecasts are provided through 2013. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Because this industry is extremely fragmented, with thousands of providers offering many different types of programs tailored to different patient populations, an effort was made to include a broad representation of groups. Companies profiled include:

Aetna

Azente Wellness

Cigna

Coleman Wellness Solutions

ConnectiCare

Corporate Wellness

ConvergenceHealth

CuraLinc Healthcare

Dynamic Wellness

Employee Health Management Systems

Hawaii Medical Assurance Association

incentaHEALTH

KC Wellness

Kersh Risk Management.

Kronos Optimal Health Company

Mayo Clinic Health Solutions'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report

Post Your Comments:

(Date:12/15/2009)... Health Technologies, Inc. (OTC Bulletin Board: VHGI) confirmed ... subsidiary of VHGI) has appointed two key industry ... with bringing the Treasure Gulch and Zero Gold ... Additionally, the company is informing interested shareholders and ... Live Investor Town Hall Meeting so that investors ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, ... - Market Forecasts to 2015, Competitive ... ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The ... Market Forecasts to 2015, Competitive Benchmarking, ... ,, http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... has released its latest research "The ...

(Date:12/15/2009)... Hosted by the Technology-based Learning SIG of ASTD,s ... best eLearning designs. This year nominees, eleven ... The Venza Group entry, a highly engaging ... was selected as the winner of the "Greater ... the panel of distinguished judges. While announcing ...

(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...

[0] VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled [0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business

... Group on Health and Pharmacy Outcomes Specialists collaborate to produce ... CHICAGO, Dec. 8 The Midwest Business Group on Health ... the second annual Pharmacy Benefits Academy (PBA) to be held ... A collaboration between MBGH and POS, the Academy is part ...

... , , MONDAY, Dec. 8 (HealthDay News) -- An international ... 40,000 people has identified 11 more regions that govern ... triglycerides. , "These locations point us to previously unsuspected ... Dr. Sekar Kathiresan, director of preventive cardiology at Massachusetts ...

... INDIANAPOLIS, Dec. 8 Amylin,Pharmaceuticals, Inc. (Nasdaq: ... LLY ),today announced that the U.S. Food and ... regulatory application for use of BYETTA(R) (exenatide),injection as stand-alone ... not achieving acceptable blood sugar control. It is likely ...

... earns regional designation , , ... the nation,s largest effort to recognize physicians for delivering ... BTE Incentive and Reward Program Endorsement. Aetna ... for meeting performance and recognition standards and principles for ...

... its acclaimed debut in 2007,MyHealthArchive revolutionized every aspect ... bringing the process into the digital age. Today,s,release ... allowing,subscribers to take charge of their health and ... their own centralized control and energizing their health,and ...

... a leading global manufacturer and marketer of nutritional supplements, today announced preliminary unaudited net sales results for the month of November ... by segment are as follows: , , , , ... NET SALES, ... ...

Other Medicine News:Health News:Pharmacy Benefits Academy Set for 2009 2 Health News:Pharmacy Benefits Academy Set for 2009 3 Health News:11 New Cholesterol Genes Identified 2 Health News:11 New Cholesterol Genes Identified 3 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 2 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 3 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 4 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 5 Health News:Health Plans Achieve Bridges to Excellence Physician Incentive and Reward Program Endorsement 2 Health News:Health Plans Achieve Bridges to Excellence Physician Incentive and Reward Program Endorsement 3 Health News:MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health 2 Health News:MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health 3 Health News:MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health 4 Health News:NBTY Announces Preliminary Unaudited Net Sales Results for November 2008 2 Health News:NBTY Announces Preliminary Unaudited Net Sales Results for November 2008 3 Health News:NBTY Announces Preliminary Unaudited Net Sales Results for November 2008 4

Pharmacy Benefits Academy Set for 2009 11 New Cholesterol Genes Identified Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission Health Plans Achieve Bridges to Excellence Physician Incentive and Reward Program Endorsement MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health NBTY Announces Preliminary Unaudited Net Sales Results for November 2008

(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... A strategic assessment of the competitive ... highest priority management responsibilities, the task ... profitability. Timely and factual competitive intelligence ...

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

[0] Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 [0] Reportlinker Adds Top Ten World's Leading Orthopedics Companies [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... to evaluate vandetanib as second-line NSCLC ... treatment in combination with docetaxel -, WILMINGTON, Del., Sept. ... show that the AstraZeneca,investigational once-daily oral anti-cancer drug vandetanib (ZACTIMA), ... advanced Non-Small Cell Lung Cancer (NSCLC). The Phase II ...

... to insulin glargine, exenatide offered added benefits of, ... used with metformin --, AMSTERDAM, Netherlands, Sept. ... and Eli Lilly and Company (NYSE: LLY ... injection,with insulin glargine on beta-cell function, glycemic control ...

Other Medicine Technology:Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 2 Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 3 Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 4 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7

Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function

... Management software- RLISYS provides ... Software, Support, and Training ... Optometry, Ophthalmology, and Opticianry- ... operations, allowing you to ...

... The Advia 120 ... to streamline laboratory workflow ... benefits. This analyzer offers ... diagnostic assays, meeting the ...

The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....

The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...

Medicine Products:

RLISYS Advia 120 K-4500 XT-1800i

Reportlinker Adds The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Produ...(es and/or sub-segments were selected tha...),Health